subscribeSubscribe
Merck-Gilead`s weekly HIV combo maintains viral suppression

Merck-Gilead`s weekly HIV combo maintains viral suppression
FIERCE BIOTECH
07 Mar 2024
Share Share
Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine

Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine
BUSINESSWIRE
22 Feb 2023
Share Share
Merck’s HIV pipeline shifts as islatravir PrEP program is discontinued

Merck’s HIV pipeline shifts as islatravir PrEP program is discontinued
Adam Zamecnik PHARMACEUTICAL-TECHNOLOGY
29 Sep 2022
Share Share
Merck to start studying lower dose of HIV drug after FDA hold

Merck to start studying lower dose of HIV drug after FDA hold
REUTERS
21 Sep 2022
Share Share
FDA pauses several trials of Merck’s investigational HIV drug

FDA pauses several trials of Merck’s investigational HIV drug
PHARMAFILE
16 Dec 2021
Share Share
FDA grounds Merck & Co.`s islatravir programme in HIV

FDA grounds Merck & Co.`s islatravir programme in HIV
REUTERS
14 Dec 2021
Share Share
U.S. FDA puts Merck’s HIV drug trials on hold

U.S. FDA puts Merck’s HIV drug trials on hold
FXEMPIRE
13 Dec 2021
Share Share
Merck Puts Clinical Holds on Studies Evaluating Islatravir for HIV-1 Infection

Merck Puts Clinical Holds on Studies Evaluating Islatravir for HIV-1 Infection
BUSINESSWIRE
13 Dec 2021
Share Share
Merck pauses 2 more trials of backbone HIV drug over red flag

Merck pauses 2 more trials of backbone HIV drug over red flag
N.P. Taylor FIERCEBIOTECH
08 Dec 2021
Share Share
Gilead and Merck Pause Enrollment for Phase 2 HIV Study Evaluating Islatravir

Gilead and Merck Pause Enrollment for Phase 2 HIV Study Evaluating Islatravir
TRIALSITENEWS
24 Nov 2021
Share Share